Shanghai Pharmaceuticals (SHA:601607, HKG:2607) completed the acquisition of a majority stake in Shanghai Hutchison Pharmaceuticals or SHPL, according to a Hong Kong Stock Exchange disclosure on Monday.
The Chinese pharmaceutical company directly and indirectly owns 60% of SHPL. The company directly owns 10% of SHPL, while its subsidiary, Shanghai TCM, will hold 50% of SHPL, the disclosure said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.